Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and omega-n-methylarginine

cetylpyridinium chloride anhydrous has been researched along with omega-n-methylarginine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carru, C; Deiana, L; Scanu, B; Sotgia, S; Zinellu, A1
Eisenach, JH; Elvebak, RL; Joyner, MJ; Nicholson, WT1

Trials

1 trial(s) available for cetylpyridinium chloride anhydrous and omega-n-methylarginine

ArticleYear
The function of vascular smooth muscle phosphodiesterase III is preserved in healthy human aging.
    Clinical and translational science, 2010, Volume: 3, Issue:5

    Topics: Aged; Aging; Blood Vessels; Cyclic Nucleotide Phosphodiesterases, Type 3; Epoprostenol; Female; Health; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Muscle, Smooth, Vascular; Nitroprusside; omega-N-Methylarginine; Vasodilation

2010

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and omega-n-methylarginine

ArticleYear
Determination of protein-incorporated methylated arginine reference values in healthy subjects whole blood and evaluation of factors affecting protein methylation.
    Clinical biochemistry, 2008, Volume: 41, Issue:14-15

    Topics: Adult; Aged; Aged, 80 and over; Arginine; Female; Health; Humans; Male; Methylation; Middle Aged; omega-N-Methylarginine; Proteins; Reference Values; Regression Analysis

2008